380P Assessing interstitial lung disease (ILD) risk in metastatic breast cancer (MBC): A comprehensive meta and network analysis of antibody-drug conjugates (ADCs) compared to available treatment options beyond first-line (1L).

Authors :: Cucciniello, L.
Giudici, F.
Di Nardo, P.
Dri, A.
Della Rossa, S.
Zottarelli, E.
Noto, C.
Foffano, L.
Pastò, B.
Bolzonello, S.
Da Ros, L.
Cudia, G.
Nascimbeni, E.
Lisanti, C.
Spazzapan, S.
Serraino, D.
Gerratana, L.
Puglisi, F.
Source :: Annals of Oncology. 2024 Supplement 2, Vol. 35, pS378-S378. 1p.
Publication Year :: 2024

Subjects :: *METASTATIC breast cancer
*INTERSTITIAL lung diseases
*ANTIBODY-drug conjugates

Full Text Access

Tools